Kilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve unaudited standalone and ....
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kilitch Drugs India Ltd has informed the stock exchanges that its Board of Directors will meet on Wednesday, 13 August 2025. The main agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30 June 2025 (Q1 FY26). The company has also confirmed that the trading window for insiders is already closed since 1 July 2025 and will reopen 48 hours after the results are publicly disclosed. This is a routine regulatory filing under SEBI LODR Regulations ahead of the earnings announcement. No financial figures or business updates are included in this intimation.
This is a procedural filing and has no direct impact on the stock. Investors should watch for the actual Q1 results on or shortly after 13 August 2025, which could move the stock depending on performance versus expectations.